• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES LLC EDWARDS SAPIEN 3 VALVE FOR TRANSCATHETER PULMONARY VALVE REPLACEMENT; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES LLC EDWARDS SAPIEN 3 VALVE FOR TRANSCATHETER PULMONARY VALVE REPLACEMENT; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED Back to Search Results
Device Problems Material Rupture (1546); Activation, Positioning or Separation Problem (2906)
Patient Problems Hemorrhage/Bleeding (1888); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 07/09/2021
Event Type  Injury  
Event Description
My (b)(6) son underwent a heart cath for transcatheter pulmonic heart valve replacement with the edwards sapien 3 valve for transcatheter pulmonary valve replacement.During deployment of the valve, the balloon ruptured and was unable to be pulled back into the sheath.This required an emergency femoral cut-down by cardiothoracic surgery with a venous and arterial repair.While attempting to retrieve the balloon, my son sustained a large volume blood loss and required several units of blood.Because the valve was not fully deployed at the time of balloon rupture, the interventional cardiologist used a second deployment system to fully seat the valve.Other results of the balloon failure included prolonged operating room time, prolonged intubation, pulmonary hemorrhage, and prolonged cvicu stay.He was suppose to stay overnight and be discharged the next day, the balloon rupture extended his stay by more than 4 days and resulted in significant increase in cost.He was discharged home with a wound vac and required an increase in follow up to attend to the wound required to retrieve the balloon.Because of the blood loss and prolonged intubation, his overall recovery time increased from a few days to more than a month.In researching this device, i noted that there was a safety notice on another one of this mfr's valves r/t balloon failure.Edwards released special instructions with the sapien 3 ultra transcatheter aortic valve replacement (tavr) after reports of balloon failure with it's delivery system.There was also a recall on the edwards intraclude intra-aortic occlusion device after three deaths were linked to ruptured cardiovascular balloons used in those systems.I would like to propose that the fda investigate the deployment system for the "edwards sapien 3 valve for transcatheter pulmonary valve replacement" to ensure that there is not a pattern of balloon failure causing harm to patients.I would be happy to sign consent for you to review any and all of my son's medical records involving this product.Of note, as my son is developmentally delayed, i am his power of attorney and have the authority to communicate and sign for release on his behalf.(b)(6).Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 VALVE FOR TRANSCATHETER PULMONARY VALVE REPLACEMENT
Type of Device
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES LLC
MDR Report Key12487637
MDR Text Key272454329
Report NumberMW5104046
Device Sequence Number1
Product Code NPV
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient Family Member or Friend
Type of Report Initial
Report Date 09/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/16/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Other;
Patient Age20 YR
Patient Weight52
-
-